Filing Details
- Accession Number:
- 0001567619-21-016869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-08 20:48:16
- Reporting Period:
- 2021-09-07
- Accepted Time:
- 2021-09-08 20:48:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1731790 | Ying Du | C/O Zai Lab Limited 4560 Jinke Road, Bldg 1, 4Th Floor Pudong, Shanghai F4 201210 | Chairwoman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2021-09-07 | 382 | $143.25 | 1,038,056 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 1,161 | $146.73 | 1,036,895 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 86 | $147.90 | 1,036,809 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 649 | $148.97 | 1,036,160 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 3,776 | $150.05 | 1,032,384 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 20,252 | $151.10 | 1,012,132 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 3,300 | $151.83 | 1,008,832 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2021-09-07 | 179 | $152.75 | 1,008,653 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Reflects a weighted average sale price of $146.73 per share, at prices ranging from $146.41 to $147.32 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $147.90 per share, at prices ranging from $147.50 to $148.04 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $148.97 per share, at prices ranging from $148.52 to $149.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $150.05 per share, at prices ranging from $149.57 to $150.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $151.10 per share, at prices ranging from $150.58 to $151.57 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $151.83 per share, at prices ranging from $151.58 to $152.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.